| 单词 | gsk | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| 释义 |
|
在项目审查期间确认，转换GSK计量吸入器制造线会使制造线简化，降低成本。 multilateralfund.org | During project review it had been [...] established that the conversion of the MDI [...] manufacturing lineat GSK would entail a simpler [...]production line, which would reduce costs. multilateralfund.org |
开发计划署需要额 外的 70,000 美元以协助GSK公司对其氟氯化碳生产线进行改型。 multilateralfund.org | UNDP would need an additional US [...] $70,000to assist GSKinconverting its [...]CFC production line. multilateralfund.org |
葛兰素史克（GSK）南非公司和勃林格殷格翰公司（BI）违反了 1998 年的竞争法。 cgfwatch.org | It found that pharmaceutical firms GlaxoSmithKline South [...] Africa(Pty)Ltd(GSK) and Boehringer Ingelheim [...](BI) had contravened the Competition Act of 1998. cgfwatch.org |
在GSK开发的数种氢氟烷烃-计量吸入器中，活性成分悬浮（而 不是溶解）在氢氟烷烃中，这就需要有更复杂的设备（也即可单段灌装的设备）并使用特 殊的容器（从纯铝罐向镀聚四氟乙烯铝罐过渡，费用为 0.37 美元）、定量阀(0.15 美元) 和 定量触动器（0.05 美元）。 multilateralfund.org | The active ingredient in several of the HFA-MDIs that have been developed by GSK is in suspension (and not in solution) in HFA, which requires more complex equipment (i.e., to allow for a single stage filling) and the use of specific cans (from plain aluminium to PTFE coated at a cost US $0.37), metering valve (US $0.15) and a metering actuator (US $0.05). multilateralfund.org |
该 项目提议使三个计量吸入器制造厂转用氢氟烷烃技术，申请同转型设备有关的一条新生产 [...] 线和一年的运转费用，由巴基斯坦的 GlaxoSmithKline（GSK）经营，并且申请额外设备以 便将 [...]Zafa 经营的制药实验室（Zafa）和 Macter International （Macter）的生产线改型。 multilateralfund.org | The project proposed the conversion of three MDI manufacturing plants to HFA technology, a request for a new production line and operating costs for one year associated with the [...] conversion of the facilities being operated [...] by GlaxoSmithKline (GSK) in Pakistan, as well [...]as a request for additional equipment [...]to retrofit the production lines being operated by Zafa Pharmaceutical Laboratories (Zafa) and Macter International (Macter). multilateralfund.org |
根据进一步的讨论，商定用于GSK公司的计量吸 入器制造线改型的供资额（在做出任何扣除之前）将削减至 [...] 1,556,084 美元（也即比最初 的申请低 2,594,413 美元），计算所依据的是 2003 年的计量吸入器生产量。 multilateralfund.org | Based on further discussions, the level of funding [...] agreed for the conversion of the MDI [...] manufacturing line at GSK(before any adjustments) [...]was reduced to US $1,556,084 (i.e., [...]US $2,594,413 lower than the original request), calculated on the basis of the 2003 MDI production levels. multilateralfund.org |
GSK最热销药品 Paxil 的专利权最近被伦敦最高法院部分推翻。 iprcommission.org | The patent on its biggest selling drug, Paxil, wasrecently partially overturned in the High Court in London. iprcommission.org |
关于GSK公司的氟氯化碳–计量吸入器生产线，秘书处提出了许多问题，涉及：基 准设备；一些申请的设备明显费用高昂；经营费用极高（也即 [...] 2,329,997 美元），而这一费 用是根据 2006 年的计量吸入器产量（3,584,611 支）和 [...]0.65 美元/每支计量吸入器的增加 费用计算得出的。 multilateralfund.org | In regard to the [...] CFC-MDI production line at GSK, a number ofissues [...]were raised concerning the baseline equipment, the apparent [...]high cost of some of the equipment items being requested, and the very high level of the operating costs (i.e., US $2,329,997), which were calculated based on an incremental cost of US $0.65/MDI and the 2006 production of MDIs (3,584,611 units). multilateralfund.org |
例如GSK正牵扯进美国的诉讼案，确定其药品 Augmentin 的专利权有效期，它是在 [...] 2017 及 2018 年到期。 iprcommission.org | For instance, GSK is currently involved [...] in litigation in the US to establish the validity of patents on its drug Augmentin [...]which expire in 2017 and 2018. iprcommission.org |
不过，如果 Zafa 公司的生产线改型，与GSK公司提供的 30%的捐助（414,510 美元） 以及所有权部分（764,080 美元）有关的扣除总额外加避免国家淘汰计划重复所需的扣除额 （378,810 美元）将超出修订的项目投资部分费用（即 203,110 美元）（超出 1,178,590 美 元）。 multilateralfund.org | However, in the event that the conversion of the production line at Zafa is ineligible, the total calculated adjustments associated with the 30 per cent contribution by GSK (US $414,510), the ownership component (US $764,080) plus the adjustment to avoid double counting from the national phase-out plan (US $378,810), are higher (i.e., US $1,178,590) than the revised cost of the investment component of the project (i.e., US $203,110). multilateralfund.org |
1981 年，巴基斯坦 GlaxoSmithKline 有限公司（GSK公司）（地方所有权占 21%） [...] 开始制造巴基斯坦的氟氯化碳计量吸入器。 multilateralfund.org | The manufacturing of CFC-MDIs in Pakistan was started in 1981 by [...] GlaxoSmithKline(GSK) PakistanLimited [...](with a 21 per cent local ownership share). multilateralfund.org |
类似调查亦於本年4月在英国进行，由葡萄适能量饮料制造商葛兰素史克(GSK)委托市场研究机构负责。 hkupop.hku.hk | Similar study was conducted in the UK by a research company which was [...] commissioned byGSK,theowning company [...]of Lucozade Energy, in April 2003. hkupop.hku.hk |
根据上述决定，GSK公司符合供资资格的计量吸入器生产线只能是当地拥有的那一 部分，其产量为 2,556,277 支计量吸入器且氟氯化碳消费量为 61ODP 吨（ 2003 年）。 multilateralfund.org | Based on the above decisions, only the locally-owned portion of the MDI production line of GSK with a production output of 2,556,277 MDIs and a CFC consumption of 61 ODP tonnes (2003) was eligible. multilateralfund.org |
与此同时，我们认识到这一模型必须与更强大的跨城市集中化互相配合，以提高效率，"GSK大中华区人力资源共享服务部招聘与HRIS经理 [...] Blake Cai 说道。 lumesse.com | Meanwhile we are conscious that this model has to be balanced with stronger centralisation [...] across cities to drive efficiency," noted Blake Cai, Recruitment & HRIS Manager, [...] HR Shared Services,GSK Greater China. lumesse.com |
尽管巴基斯坦GSK公司将申请 800,000 美元用于开发柳丁氨醇/ 氢氟烷烃-计量吸入器，但新配方只需要较为简单的计量吸入器生产线，并可分两个阶段充 [...] 填容器，因而与最初的项目相比费用较低（796,700 美元）， 经营费用（以 2006 [...]年的消费 量为基础计算为 609,384 美元）也较低。 multilateralfund.org | Although US $800,000 would be required for the development of a [...] salbutamol HFA-MDI by GSKPakistan, the new [...]formulation will require a simpler MDI production [...]line that allows for filling the cans in two stages and, therefore, at a lower cost (US $796,700) and lower operating costs (US $609,384 based on the 2006 level of consumption) as compared to the original project. multilateralfund.org |
因此，母公司授权巴基斯坦GSK公司生产自有的氢 氟烷烃-计量吸入器配方。 multilateralfund.org | As such, the parent [...] company hasauthorized GSK Pakistan toproduce [...]its own HFA-MDI formulation. multilateralfund.org |
开发计划署还指出，由于巴基斯坦的环境条件，巴基斯坦GSK公司与其母公司之间 进一步讨论初步提案也即由GSK公司向巴基斯坦GSK公司提供氢氟烷烃配方的事情已不 再可行，这将使得难以确保生产质量。 multilateralfund.org | UNDP also indicated that further to discussions betweenGSK Pakistan with [...] its parent company the initial proposal, withGSK providing the HFA formulation to GSK Pakistan, was no longer viable due to [...]environmental conditions in the country, which will make it difficult to ensure the quality of the product. multilateralfund.org |
食物安全中心已通知业界，并会与GSK保持密切联络，以跟进回收情况。 cfs.gov.hk | The Centre for Food Safety has alerted the trade and [...] will workclosely with GSK to monitor the recall [...]progress. cfs.gov.hk |
经外资所有权部分（在GSK公司中占 79%）和对应供资（在 Zafa 公司和 Macter 中 分别占 30%）扣除之后，估计淘汰巴基斯坦计量吸入器制造中使用的各类氟氯化碳的费用 总额为 2,076,202 美元，外加用于执行过渡战略的 181,000 美元。 multilateralfund.org | The total cost of the phase-out of CFCs used in the manufacture of MDIs in Pakistan has been estimated at US $2,076,202 after adjustments due to the foreign ownership component (79 per cent for GSK) and counterpart funding (30 per cent each for Zafa and Macter), plus US $181,000 for the implementation of the transition strategy. multilateralfund.org |
(a) 巴基斯坦政府向第四十一次会议提交的巴基斯坦国家方案最新报告称，GSK是该国唯一制造计量吸入器的公司，其氟氯化碳消费量为 [...] 69.4 ODP 吨 multilateralfund.org | (a) Pakistan’s country programme update, submitted by the [...] Government of Pakistan to the 41st [...] Meeting, reported thatGSK wasthe only company [...]manufacturing MDIs in the country with [...]a CFC consumption of 69.4 ODP tonnes multilateralfund.org |
人人有权享有能达到的最高标准身心健康权利问题前特别报告员保罗·亨 特访问了伦敦的制药公司葛兰素史克(GSK)。 daccess-ods.un.org | The former Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of [...] physical and mental health, Paul Hunt, undertook a mission to [...] GlaxoSmithKlyne(GSK),a pharmaceutical [...]company in London. daccess-ods.un.org |
开发计划署解释说，资本和经营费用极高是GSK使用的充填氢氟烷烃计量吸入器的方法造成的。 multilateralfund.org | UNDP explained that the very high level of capital and operating costs was due to the [...] methodology usedbyGSK in filling HFA-MDIs. multilateralfund.org |
葛兰素史克(GSK)的临床统计学总监、生物统计学公共卫生博士(DrPH) Marla [...] Curran是该研究工作组的成员。 mdsol.com | Marla Curran, director of clinical statistics and doctor of [...] public health (DrPH) in biostatistics [...] at GlaxoSmithKline(GSK),was part of the study [...]working group and has driven efforts [...]to increase efficiency across GSK trials. mdsol.com |
我们相信这一变革所带来的更好的数据完整性、准确性以及分析报表实质性地提升了共享服务团队的交付周期、成本以及服务的交付，使其成为GSK业务更好的合作伙伴。 lumesse.com | We believe that the better data integrity, accuracy, and analytical reports that have come after the change have genuinely improved the [...] shared-service team's working lead time, cost, and service delivery and made it a [...] better partner withthe GSK business. lumesse.com |
(a) 用一条 Macromat [...] 灌装线和相关的压力灌装和制备罐替代现有生产线，并减 少现有的领域，以淘汰GSK公司用于制造柳丁氨醇的 82.6 ODP 吨各类氟氯 [...]化碳（根据 2006 年的计量吸入器生产量计算），总费用为 1,820,500 [...]美元（不 包括因外资所有权部分造成的扣除）。 multilateralfund.org | (a) Phase-out of 82.6 ODP tonnes of CFCs (based on the 2006 MDI [...] production level) used in the [...] manufacturing of salbutamolatGSK by replacing the equipment [...]in the current production line [...]with a single Macromat filling line and associated pressure filling and preparation vessel, and modifying the existing area at a total cost of US $1,820,500 (before adjustment due to foreign ownership component). multilateralfund.org |
作为GSK全球招聘方案实施的一部分，Lumesse中国团队在2011年初仅用了三个月就 [...] 在一个项目中完成本地实施Lumesse TalentLink方案，包括系统测试与用户培训在内。 lumesse.com | Aspartofthe GSK global recruitment [...] solution implementation, the Lumesse China team took just three months in early 2011 [...]to implement Lumesse TalentLink solutions locally in a project that that included system tests and user training. lumesse.com |
英汉双解词典包含2273206条英汉词条，基本涵盖了全部常用单词的翻译及用法，是英语学习的有利工具。